Phase II Trial of Lonafarnib (a Farnesyltransferase Inhibitor) for Progeria
about
Phase II Trial of Lonafarnib (a Farnesyltransferase Inhibitor) for Progeria
description
clinical trial
@en
klinisch onderzoek
@nl
name
Phase II Trial of Lonafarnib (a Farnesyltransferase Inhibitor) for Progeria
@en
type
label
Phase II Trial of Lonafarnib (a Farnesyltransferase Inhibitor) for Progeria
@en
prefLabel
Phase II Trial of Lonafarnib (a Farnesyltransferase Inhibitor) for Progeria
@en
P1476
An Open Label Dose Adjusted Ph ...... S) and Progeroid Laminopathies
@en
P3098
NCT00425607
P4844
P580
2007-05-01T00:00:00Z
P582
2009-10-01T00:00:00Z